Funded by the Centers for Disease Control and Prevention (CDC), the mission of the Cancer Prevention and Control Research Network (CPCRN) is to accelerate the adoption and implementation of evidence-based cancer prevention and control strategies in communities and clinical care settings across the U.S., with a special focus on underserved populations. On the basis of a long-term collaboration, Risendal et al. outline how evidence-based cancer prevention and control strategies can inform the public health response to coronavirus disease 2019 (COVID-19) and reduce disparities. Applying the Quality Cancer Survivorship Care Framework while adapting to COVID-19 to promote quality healthcare delivery to cancer survivors, the objective of this article is to address the implications for cancer survivorship care on the basis of CPCRN experience. In this paper, the importance of bidirectional knowledge sharing and strategic communications between cancer survivors, as defined by the National Cancer Institute, and the healthcare system are underscored. This document represents a consensus across the CPCRN Cancer Survivorship Working Group, a subgroup of CPCRN members who represent all stakeholder groups within the network, and was supported by the CPCRN Steering Committee
